Concepedia

Publication | Closed Access

OP 85 Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab

DOI

95

Citations

0

References

2011

Year

Kimio Yonesaka, Kreshnik Zejnullahu, Isamu Okamoto, Takahiro Satoh, Federico Cappuzzo, John Souglakos, J. A. Engelman, M. Varella-Garcia, Kazuhiko Nakagawa, Pasi A. Jänne
European Journal of Cancer

No additional data available for this publication yet. Check back later!